Literature DB >> 33512714

S-cone contribution to the acute melatonin suppression response in humans.

Timothy M Brown1, Kavita Thapan2, Josephine Arendt2, Victoria L Revell2,3, Debra J Skene2.   

Abstract

Light influences diverse aspects of human physiology and behaviour including neuroendocrine function, the circadian system and sleep. A role for melanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs) in driving such effects is well established. However, rod and/or cone signals routed through ipRGCs could also influence "non-visual" spectral sensitivity. In humans, this has been most extensively studied for acute, light-dependent, suppression of nocturnal melatonin production. Of the published action spectra for melatonin suppression, one demonstrates a spectral sensitivity consistent with that expected for melanopsin while our own (using briefer 30 minute light exposures) displays very high sensitivity to short wavelength light, suggesting a contribution of S-cones. To clarify that possibility, six healthy young male participants were each exposed to 30 minutes of five irradiances of 415 nm monochromatic light (1-40 µW/cm2 ) across different nights. These data were then combined with the original action spectrum. The aggregated data are incompatible with the involvement of any single-opsin and multi-opsin models based on the original action spectrum (including Circadian Stimulus) fail to predict the responses to 415 nm stimuli. Instead, the extended action spectrum can be most simply approximated by an ~2:1 combination of melanopsin and S-cone signals. Such a model also better describes the magnitude of melatonin suppression observed in other studies using an equivalent 30 minute mono- or polychromatic light paradigm but not those using longer (90 minute) light exposures. In sum, these data provide evidence for an initial S-cone contribution to melatonin suppression that rapidly decays under extended light exposure.
© 2021 The Authors. Journal of Pineal Research published by John Wiley & Sons Ltd.

Entities:  

Keywords:  S-cone; action spectrum; melatonin suppression; spectral sensitivity

Mesh:

Substances:

Year:  2021        PMID: 33512714     DOI: 10.1111/jpi.12719

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  5 in total

1.  High sensitivity of melatonin suppression response to evening light in preschool-aged children.

Authors:  Lauren E Hartstein; Cecilia Diniz Behn; Lameese D Akacem; Nora Stack; Kenneth P Wright; Monique K LeBourgeois
Journal:  J Pineal Res       Date:  2022-01-08       Impact factor: 13.007

2.  Spectral dependency of the human pupillary light reflex. Influences of pre-adaptation and chronotype.

Authors:  Johannes Zauner; Herbert Plischke; Hans Strasburger
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

3.  Optimising metameric spectra for integrative lighting to modulate the circadian system without affecting visual appearance.

Authors:  Babak Zandi; Oliver Stefani; Alexander Herzog; Luc J M Schlangen; Quang Vinh Trinh; Tran Quoc Khanh
Journal:  Sci Rep       Date:  2021-11-30       Impact factor: 4.379

4.  Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adults.

Authors:  Timothy M Brown; George C Brainard; Christian Cajochen; Charles A Czeisler; John P Hanifin; Steven W Lockley; Robert J Lucas; Mirjam Münch; John B O'Hagan; Stuart N Peirson; Luke L A Price; Till Roenneberg; Luc J M Schlangen; Debra J Skene; Manuel Spitschan; Céline Vetter; Phyllis C Zee; Kenneth P Wright
Journal:  PLoS Biol       Date:  2022-03-17       Impact factor: 8.029

5.  Predicting melatonin suppression by light in humans: Unifying photoreceptor-based equivalent daylight illuminances, spectral composition, timing and duration of light exposure.

Authors:  Marina C Giménez; Oliver Stefani; Christian Cajochen; Dieter Lang; Gunnar Deuring; Luc J M Schlangen
Journal:  J Pineal Res       Date:  2022-01-20       Impact factor: 12.081

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.